1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. North America E. coli Testing Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. North America E. coli Testing Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. North America E. coli Testing Market Regional Analysis
6.2 North America E. coli Testing Market Revenue 2017-2027 (US$ Million)
6.3 North America E. coli Testing Market Forecast Analysis
7. North America E. coli Testing Market Analysis – by Technology
7.1 Monoclonal Antibodies
- 7.1.1 Overview
- 7.1.2 Monoclonal Antibodies: North America E. coli Testing Market – Revenue and Forecast, 2017-2027 (US$ Million)
7.2 Differential Light Scattering
- 7.2.1 Overview
- 7.2.2 Differential Light Scattering: North America E. coli Testing Market – Revenue and Forecast, 2017-2027 (US$ Million)
7.3 Molecular Diagnostics
- 7.3.1 Overview
- 7.3.2 Molecular Diagnostics: North America E. coli Testing Market – Revenue and Forecast, 2017-2027 (US$ Million)
7.4 Immunoassays
- 7.4.1 Overview
- 7.4.2 Immunoassays: North America E. coli Testing Market – Revenue and Forecast, 2017-2027 (US$ Million)
7.5 Chromatography
- 7.5.1 Overview
- 7.5.2 Chromatography: North America E. coli Testing Market – Revenue and Forecast, 2017-2027 (US$ Million)
7.6 Flow Cytometry
- 7.6.1 Overview
- 7.6.2 Flow Cytometry: North America E. coli Testing Market – Revenue and Forecast, 2017-2027 (US$ Million)
7.7 Gel Microdroplets
- 7.7.1 Overview
- 7.7.2 Gel Microdroplets: North America E. coli Testing Market – Revenue and Forecast, 2017-2027 (US$ Million)
7.8 Diagnostic Imaging
- 7.8.1 Overview
- 7.8.2 Diagnostic Imaging: North America E. coli Testing Market – Revenue and Forecast, 2017-2027 (US$ Million)
8. North America E. coli Testing Market Analysis – by End User
8.1 Commercial or Private Labs
- 8.1.1 Overview
- 8.1.2 Commercial or Private Labs: North America E. coli Testing Market – Revenue and Forecast, 2017-2027 (US$ Million)
8.2 Physician Offices
- 8.2.1 Overview
- 8.2.2 Physician Offices: North America E. coli Testing Market – Revenue and Forecast, 2017-2027 (US$ Million)
8.3 Hospitals
- 8.3.1 Overview
- 8.3.2 Hospitals: North America E. coli Testing Market – Revenue and Forecast, 2017-2027 (US$ Million)
8.4 Public Health Labs
- 8.4.1 Overview
- 8.4.2 Public Health Labs: North America E. coli Testing Market – Revenue and Forecast, 2017-2027 (US$ Million)
8.5 Academic Research Institutes
- 8.5.1 Overview
- 8.5.2 Academic Research Institutes: North America E. coli Testing Market – Revenue and Forecast, 2017-2027 (US$ Million)
9. North America E. coli Testing Market – North America Analysis
9.1 Overview
9.2 North America
- 9.2.1 North America E. coli Testing Market Breakdown, by Key
Country, 2020 and 2027 (%)
- 9.2.1.1 North America E. coli Testing Market – Revenue and
Forecast Analysis – by Country
- 9.2.1.1 US:
North America E. coli Testing Market – Revenue and Forecast to 2027 (US$ Million)
- 9.2.1.1.1 US: North America E. coli Testing Market Breakdown, by Technology
- 9.2.1.1.2 US: North America E. coli Testing Market Breakdown, by End User
- 9.2.1.2 Canada:
North America E. coli Testing Market – Revenue and Forecast to 2027 (US$ Million)
- 9.2.1.2.1 Canada: North America E. coli Testing Market Breakdown, by Technology
- 9.2.1.2.2 Canada: North America E. coli Testing Market Breakdown, by End User
- 9.2.1.3 Mexico :
North America E. coli Testing Market – Revenue and Forecast to 2027 (US$ Million)
- 9.2.1.3.1 Mexico : North America E. coli Testing Market Breakdown, by Technology
- 9.2.1.3.2 Mexico : North America E. coli Testing Market Breakdown, by End User
10. Competitive Landscape
10.1 Heat Map Analysis
10.2 Company Positioning and Concentration
11. Industry Landscape
11.1 Overview
11.2 Market Initiative
11.3 Partnerships and Collaborations
11.4 Other Developments
12. Company Profiles
12.1 Bio-Rad Laboratories, Inc
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 Pro-Lab Diagnostics, Inc.
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 Abbott (Alere Inc.)
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 IDEXX Laboratories, Inc.
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 Meridian Bioscience, Inc.
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 BD
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
12.7 Thermo Fisher Scientific, Inc.
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
12.8 NEOGEN Corporation
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments
12.9 Hologic, Inc.
- 12.9.1 Key Facts
- 12.9.2 Business Description
- 12.9.3 Products and Services
- 12.9.4 Financial Overview
- 12.9.5 SWOT Analysis
- 12.9.6 Key Developments
13. Appendix
13.1 About Business Market Insights
13.2 List of Abbreviations
Get Free Sample For North America E. coli Testing Market
